TNSN01121A1 - Antibiotiques nouveaux faisant partie des macrolides, et compositions les contenant - Google Patents
Antibiotiques nouveaux faisant partie des macrolides, et compositions les contenantInfo
- Publication number
- TNSN01121A1 TNSN01121A1 TNTNSN01121A TNSN01121A TNSN01121A1 TN SN01121 A1 TNSN01121 A1 TN SN01121A1 TN TNSN01121 A TNTNSN01121 A TN TNSN01121A TN SN01121 A TNSN01121 A TN SN01121A TN SN01121 A1 TNSN01121 A1 TN SN01121A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compositions containing
- antibiotics including
- novel antibiotics
- including macrolides
- macrolides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
L'INVENTION CONCERNE UN ANTIBIOTIQUE MACROLIDE DE FORMULE (I) : DANS LAQUELLE R1, R2, R3, R4, R5, R6, R7, R8, X ET Z REPRESENTENT DIVERS RADICAUX. ELLE CONCERNE EGALEMENT UN PROCEDE POUR SA PREPARATION, ET UNE COMPOSITION PHARMACEUTIQUE LE CONTENANT. APPLICATION : UTILISATION DE CE COMPOSE OU DE CETTE COMPOSITION POUR LE TRAITEMENT D'INFECTIONS BACTERIENNES OU D'INFECTIONS PAR DES PROTOZOAIRES, CHEZ DES MAMMIFERES, DES POISSONS OU DES OISEAUX.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22359100P | 2000-08-07 | 2000-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN01121A1 true TNSN01121A1 (fr) | 2005-11-10 |
Family
ID=22837162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN01121A TNSN01121A1 (fr) | 2000-08-07 | 2001-08-06 | Antibiotiques nouveaux faisant partie des macrolides, et compositions les contenant |
Country Status (17)
Country | Link |
---|---|
US (2) | US20020115621A1 (fr) |
EP (1) | EP1307468A1 (fr) |
JP (1) | JP2004505987A (fr) |
AP (1) | AP2001002236A0 (fr) |
AR (1) | AR034695A1 (fr) |
AU (1) | AU2001272719A1 (fr) |
BR (1) | BR0112863A (fr) |
CA (1) | CA2419044A1 (fr) |
DO (1) | DOP2001000228A (fr) |
GT (1) | GT200100159A (fr) |
HN (1) | HN2001000176A (fr) |
MX (1) | MXPA03001148A (fr) |
PA (1) | PA8524501A1 (fr) |
PE (1) | PE20020468A1 (fr) |
TN (1) | TNSN01121A1 (fr) |
UY (1) | UY26870A1 (fr) |
WO (1) | WO2002012260A1 (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003500414A (ja) | 1999-05-24 | 2003-01-07 | ファイザー・プロダクツ・インク | 13−メチルエリスロマイシン誘導体 |
DE60138876D1 (de) * | 2000-03-28 | 2009-07-16 | Sandoz Ag | Geschmackmaskierte granulierte teilchen |
US6825172B2 (en) | 2002-05-31 | 2004-11-30 | Janssen Pharmaceutica, Nv | 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents |
HRP20020885B1 (en) | 2002-11-11 | 2007-05-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A |
US7601695B2 (en) | 2003-03-10 | 2009-10-13 | Optimer Pharmaceuticals, Inc. | Antibacterial agents |
GB0310981D0 (en) * | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
HRP20030381B1 (en) * | 2003-05-14 | 2007-05-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A |
WO2005030227A1 (fr) | 2003-09-23 | 2005-04-07 | Enanta Pharmaceuticals, Inc. | Derives 9a-azalide 11-3c-bicycliques |
US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
BRPI0513903A (pt) * | 2004-07-28 | 2008-05-20 | Ranbaxy Lab Ltd | derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos |
US7402568B2 (en) | 2004-09-29 | 2008-07-22 | Enanta Pharmaceuticals, Inc. | Bicyclic 9a-azalide derivatives |
WO2006046112A2 (fr) * | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Derives de cetolides utiles comme agents antibacteriens |
EP2233493A1 (fr) * | 2004-12-21 | 2010-09-29 | Pfizer Products Inc. | Macrolides |
US7271155B2 (en) | 2005-01-07 | 2007-09-18 | Enanta Pharmaceuticals, Inc. | 9A, 11-2C-bicyclic 9a-azalide derivatives |
DE602006004555D1 (de) | 2005-01-13 | 2009-02-12 | Glaxosmithkline Zagreb | Decladinosyl-macrolide mit entzündungshemmender wirkung |
US20090130225A1 (en) * | 2005-11-23 | 2009-05-21 | Anjan Chakrabarti | Macrolides derivatives as antibacterial agents |
WO2007060518A2 (fr) * | 2005-11-23 | 2007-05-31 | Ranbaxy Laboratories Limited | Dérivés de cétolide en tant qu'agents antibactériens |
WO2007143507A2 (fr) * | 2006-06-05 | 2007-12-13 | Auspex Pharmaceuticals, Inc. | Préparation et utilité d'analogues d'érythromycine substitués |
WO2009055557A1 (fr) | 2007-10-25 | 2009-04-30 | Cempra Pharmaceuticals, Inc. | Procédé pour la préparation d'agents antibactériens macrolides |
US8796232B2 (en) | 2008-10-24 | 2014-08-05 | Cempra Pharmaceuticals, Inc. | Methods for treating resistant diseases using triazole containing macrolides |
US9937194B1 (en) * | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
JP5914335B2 (ja) | 2009-09-10 | 2016-05-11 | センプラ ファーマシューティカルズ,インコーポレイテッド | マラリア、結核、及びmac病の治療方法 |
WO2011119604A1 (fr) | 2010-03-22 | 2011-09-29 | Cempra Pharmaceuticals, Inc. | Formes cristallines d'un macrolide et leurs utilisations |
BR112012029586A2 (pt) | 2010-05-20 | 2016-08-02 | Cempra Pharmaceuticals Inc | processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos |
KR20180110181A (ko) | 2010-09-10 | 2018-10-08 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
CA2868262A1 (fr) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Formulations parenterales pour l'administration d'antibiotiques macrolides |
CN105163785A (zh) | 2013-03-14 | 2015-12-16 | 森普拉制药公司 | 用于治疗呼吸道疾病的方法及其制剂 |
CA2907085A1 (fr) | 2013-03-15 | 2014-09-18 | Cempra Pharmaceuticals, Inc. | Procedes convergents de preparation d'agents antibacteriens macrolides |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US100518A (en) | 1870-03-08 | Roland s | ||
US40007A (en) | 1863-09-22 | Improvement in railroad-car brakes | ||
US61857A (en) | 1867-02-05 | Improvement in top-drivers or spinners | ||
US61856A (en) | 1867-02-05 | Enos s | ||
US156027A (en) | 1874-10-20 | Improvement in loom-shuttles | ||
US25937A (en) | 1859-11-01 | ballou | ||
US3923784A (en) | 1973-09-10 | 1975-12-02 | Hoffmann La Roche | Erythromycin a derivatives |
SI8110592A8 (en) | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
US4474768A (en) | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
US5141926A (en) * | 1990-04-18 | 1992-08-25 | Abbott Laboratories | Erythromycin derivatives |
US5523399A (en) | 1991-12-27 | 1996-06-04 | Taisho Pharmaceutical Co., Ltd. | 5-O-desosaminylerythronolide derivatives |
FR2745290B1 (fr) | 1996-02-28 | 1998-04-03 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR2748746B1 (fr) | 1996-05-14 | 1998-08-14 | Hoechst Marion Roussel Inc | Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine |
US5804565A (en) | 1996-09-24 | 1998-09-08 | Taisho Pharmaceutical Co., Ltd. | Erythromycin A derivatives |
CN1238777A (zh) | 1996-11-27 | 1999-12-15 | 大正制药株式会社 | 红霉素a衍生物 |
AU6932098A (en) | 1997-05-09 | 1998-12-08 | Pfizer Products Inc. | Erythromycin derivatives |
EP0895999A1 (fr) | 1997-08-06 | 1999-02-10 | Pfizer Products Inc. | Macrolides antibiotiques substitués C"-4 |
ZA987689B (en) * | 1997-09-02 | 1999-02-24 | Abbott Lab | 3-descladinose 6-O substituted erythromycin derivatives |
JP2004514643A (ja) | 1997-10-29 | 2004-05-20 | 大正製薬株式会社 | エリスロマイシンa誘導体 |
PA8461401A1 (es) | 1997-10-29 | 2000-05-24 | Pfizer Prod Inc | Derivados de eritromicina triciclicos |
ZA989835B (en) | 1997-10-29 | 1999-05-05 | Taisho Pharmaceutical Co Ltd | Erythromycin a derivatives |
HN1998000159A (es) | 1997-10-29 | 1999-02-09 | Monsanto Co | Derivados de 9- amino - 3 ceto eritromicina |
CN1284961A (zh) * | 1997-12-11 | 2001-02-21 | 北陆制药株式会社 | 红霉素衍生物 |
AP1060A (en) | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
WO1999062920A1 (fr) | 1998-06-03 | 1999-12-09 | Pfizer Products Inc. | Derives 3-keto tricycliques de 6-o-methylerythromycine |
HUP0105190A3 (en) | 1999-01-27 | 2003-03-28 | Pfizer Prod Inc | Ketolide antibiotics, medicaments containing them and their use |
WO2001010878A1 (fr) | 1999-08-06 | 2001-02-15 | Taisho Pharmaceutical Co., Ltd. | Derives d'erythromycine a |
AU6183800A (en) | 1999-08-06 | 2001-03-05 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
US6498146B1 (en) * | 1999-10-28 | 2002-12-24 | Pfizer Inc | Erythromycin derivatives |
EP1101769A3 (fr) | 1999-11-18 | 2001-10-24 | Pfizer Products Inc. | Dérivés de l'érythromycine contenant de l'azote |
-
2001
- 2001-08-01 US US09/920,141 patent/US20020115621A1/en not_active Abandoned
- 2001-08-06 CA CA002419044A patent/CA2419044A1/fr not_active Abandoned
- 2001-08-06 AP APAP/P/2001/002236A patent/AP2001002236A0/en unknown
- 2001-08-06 BR BR0112863-9A patent/BR0112863A/pt not_active IP Right Cessation
- 2001-08-06 TN TNTNSN01121A patent/TNSN01121A1/fr unknown
- 2001-08-06 HN HN2001000176A patent/HN2001000176A/es unknown
- 2001-08-06 GT GT200100159A patent/GT200100159A/es unknown
- 2001-08-06 AR ARP010103760A patent/AR034695A1/es not_active Application Discontinuation
- 2001-08-06 PE PE2001000778A patent/PE20020468A1/es not_active Application Discontinuation
- 2001-08-06 EP EP01951875A patent/EP1307468A1/fr not_active Withdrawn
- 2001-08-06 AU AU2001272719A patent/AU2001272719A1/en not_active Abandoned
- 2001-08-06 MX MXPA03001148A patent/MXPA03001148A/es active IP Right Grant
- 2001-08-06 JP JP2002518234A patent/JP2004505987A/ja not_active Ceased
- 2001-08-06 WO PCT/IB2001/001403 patent/WO2002012260A1/fr not_active Application Discontinuation
- 2001-08-07 UY UY26870A patent/UY26870A1/es not_active Application Discontinuation
- 2001-08-07 DO DO2001000228A patent/DOP2001000228A/es unknown
- 2001-08-07 PA PA20018524501A patent/PA8524501A1/es unknown
-
2003
- 2003-06-03 US US10/454,354 patent/US6849608B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BR0112863A (pt) | 2003-07-01 |
GT200100159A (es) | 2002-03-22 |
PE20020468A1 (es) | 2002-06-14 |
DOP2001000228A (es) | 2002-09-30 |
CA2419044A1 (fr) | 2002-02-14 |
HN2001000176A (es) | 2001-10-08 |
US6849608B2 (en) | 2005-02-01 |
AP2001002236A0 (en) | 2001-09-30 |
AU2001272719A1 (en) | 2002-02-18 |
PA8524501A1 (es) | 2002-08-29 |
JP2004505987A (ja) | 2004-02-26 |
EP1307468A1 (fr) | 2003-05-07 |
MXPA03001148A (es) | 2003-06-09 |
US20020115621A1 (en) | 2002-08-22 |
US20040009930A1 (en) | 2004-01-15 |
AR034695A1 (es) | 2004-03-17 |
UY26870A1 (es) | 2002-03-22 |
WO2002012260A1 (fr) | 2002-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN01121A1 (fr) | Antibiotiques nouveaux faisant partie des macrolides, et compositions les contenant | |
TNSN99205A1 (fr) | Macrolides antibiotiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN98238A1 (fr) | Macrolides nouveaux | |
TNSN98194A1 (fr) | Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98082A1 (fr) | DERIVES SUBSTITUES EN C - 4 DE 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCINE A. | |
TNSN00191A1 (fr) | Composes nouveaux, compositions les contenant et leur utilisation dans le traitement d'une ischemie | |
MA26717A1 (fr) | Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN01091A1 (fr) | Derives bicycliques nouveaux, compositions les contenant et leur utilisation pour le traitement d'une croissance cellulaire anormale | |
TNSN00108A1 (fr) | Derives d'erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99214A1 (fr) | Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99106A1 (fr) | Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99236A1 (fr) | Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN00092A1 (fr) | Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99172A1 (fr) | 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN00028A1 (fr) | Derives de quinoleine -2-one a substituant heteroaryle nouveaux procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99095A1 (fr) | 4 - phenylpiperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98084A1 (fr) | Derives de macrolides substitues en position c-4 | |
BG104640A (en) | Novel erythromycin derivatives | |
TNSN99227A1 (fr) | Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN01126A1 (fr) | Imidazoles substitues nouveaux, procede pour leur preparation et compositions les contenant | |
TNSN01046A1 (fr) | Ethers de diphenyle utiles en therapeutique | |
TNSN98196A1 (fr) | Derives d'erythromycine tricycliques nouveaux, procede pour leur preparation et compositions les contenant | |
TNSN00250A1 (fr) | Composes nouveaux inhibiteurs de pcp, procede pour leur preparation et compositions les contenant | |
TNSN99111A1 (fr) | Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
ES2159733T3 (es) | Compuestos de dialquiltiacumicina. |